TXMD

Q: What is the price of TherapeuticsMD (TXMD) today?

The current price of TherapeuticsMD (TXMD) is $ 2.04, representing a 64.52% gain over the past year. The stock began the year trading around $ 1.63 and is currently priced at $ 2.04. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does TherapeuticsMD (TXMD) pay dividends?

TherapeuticsMD (TXMD) did not pay dividends over the past year.

TherapeuticsMD Inc.

Price

$ 2.04

return (12m)

64.52%

p/e

-46.11

p/bv

0.98

DIVIDEND YIELD

0.00%

TXMD price

TXMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TXMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.99%

3 months

-5.56%

1 year

64.52%

2 years

8.51%

5 years

-96.45%

10 years

-99.52%

Fundamentals TXMD

review the fundamentals of TherapeuticsMD shares

P/E

-46.11

Sector: -2.28 Industry: 0.31

P/S (PSR)

8.73

Sector: 1.95 Industry: 2.43

P/BV

0.98

Sector: 2.14 Industry: 2.27

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-1.51%

Sector: -26.12% Industry: -24.85%

ROE

-2.12%

Sector: -29.95% Industry: -34.28%

ROIC

-20.15%

Sector: -417.03% Industry: -76.42%

NET MARGIN

-18.94%

Sector: -28.23% Industry: -31.32%

GROSS MARGIN

100.00%

Sector: 44.62% Industry: 50.66%

OPERATING MARGIN

-100.00%

Sector: -23.34% Industry: -27.97%

EV/EBITDA

-8.70

Sector: -0.65 Industry: 0.70

EV/EBIT

-6.23

Sector: -1.83 Industry: -0.26

PRICE-TO-ASSETS

0.70

Sector: 1.15 Industry: 1.21

BVPS

2.24

Sector: 3.73 Industry: 4.81

EPS

-0.05

Sector: -0.90 Industry: -0.84

EQUITY-TO-ASSETS RATIO

0.71

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.29

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

-48.97%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-68.09%

Sector: - Industry: -

Fundamentals TXMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	38.33	33.17	86.53%	0.70%	$ 791.14 B	31.66%
ISRG	57.46	9.73	16.93%	0.00%	$ 171.19 B	28.15%
TMO	25.52	3.36	13.15%	0.37%	$ 174.73 B	15.15%
SNY	12.52	1.36	10.86%	4.73%	$ 114.19 B	18.68%
NVS	19.91	5.98	30.04%	2.13%	$ 278.48 B	24.67%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	23.17	2.17	9.38%	3.41%	$ 106.90 B	13.00%
GSK	14.35	5.12	35.71%	3.22%	$ 109.42 B	17.48%
CVS	55.99	1.31	2.35%	3.41%	$ 98.98 B	0.44%
BSX	25.86	0.00	0.00%	0.00%	$ 92.17 B	17.29%
TMDX	19.82	7.97	40.22%	0.00%	$ 3.77 B	31.43%
HCA	14.26	-32.53	-228.14%	0.68%	$ 96.87 B	8.89%
IDXX	42.73	28.20	65.99%	0.00%	$ 45.27 B	24.62%
RMD	21.60	5.08	23.51%	1.06%	$ 32.10 B	27.53%
DHR	34.02	2.37	6.97%	0.77%	$ 125.49 B	14.89%
INMD	9.67	1.33	13.73%	0.00%	$ 907.20 M	25.32%
PHG	25.18	2.03	8.06%	3.23%	$ 26.12 B	5.07%
SYK	38.64	5.59	14.48%	1.04%	$ 125.44 B	12.92%
FMS	11.54	0.78	6.75%	3.46%	$ 13.02 B	5.02%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

TXMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/10/2008	06/10/2008	666,66666600

ABOUT TherapeuticsMD

TherapeuticsMD Inc.

Average Investor10 user rating

4.0 (0 people)

United States

119 years

Founded: 1907

2007

Time since IPO - 19 years

400

Employees

TherapeuticsMD Inc. (United States) is listed on the Nasdaq and has a market capitalization of $26.28 Millions, with shareholders equity totaling $26.88 Millions.

The company employs approximately 400 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, TherapeuticsMD Inc. reported $3.01 Millions in revenue, generating net income of $-570.00 Thousand.

Key financial metrics include a P/E ratio of -46.11, a price-to-book (P/B) ratio of 0.98, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TXMD.

Market cap

$ 26.28 Millions

Net worth

$ 26.88 Millions

$ 26,880,000.00

Assets

$ 37.66 Millions

$ 37,660,000.00

Total Shares Outstanding

12.00 Millions

12,000,000

Average Daily Trading Volume

$ 23.64 Thousand

$ 23,640.00

Sector

Health

Industry

Pharmaceutical Products

TXMD

TXMD revenue and profits

Financial Results TXMD

DRAG THE FRAME TO SEE MORE DATA

TXMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 83.29 24,31% (12M)

P/E

55.99

3.41%

ROE

2.35%

P/BV

1.31

CI - Cigna

$ 290.58 --10,97% (12M)

P/E

10.67

2.21%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 53.69 --9,63% (12M)

P/E

-3.08

0.00%

ROE

-33.28%

P/BV

1.03

HUM - Humana

$ 236.44 --5,81% (12M)

P/E

21.74

1.64%

ROE

6.70%

P/BV

1.46

LLY - Eli Lilly

$ 934.60 14,30% (12M)

P/E

38.33

0.70%

ROE

86.53%

P/BV

33.17

HCA - HCA Healthcare

$ 434.45 27,51% (12M)

P/E

14.26

0.68%

ROE

-228.14%

P/BV

-32.53

NVS - Novartis

$ 147.85 35,40% (12M)

P/E

19.91

2.13%

ROE

30.04%

P/BV

5.98